ISSN 0042-0018
Vol. 39, Issue 1, 2004January 01, 2004 PDT
The Superiority of Direct Proof of Monopoly Power and Anticompetitive Effects in Antitrust Cases Involving Delayed Entry of Generic Drugs
The Superiority of Direct Proof of Monopoly Power and Anticompetitive Effects in Antitrust Cases Involving Delayed Entry of Generic Drugs
Eric L. Cramer, Daniel Berger,
AntitrustGeneric DrugsMonopolyAnticompetitiveHatch-WaxmanIntellectual PropertyDelayed Generic EntryPharmaceutical Industry
Eric L. Cramer & Daniel Berger, The Superiority of Direct Proof of Monopoly Power and Anticompetitive Effects in Antitrust Cases Involving Delayed Entry of Generic Drugs, 39 University of San Francisco Law Review 4 (2004).